| Target Species |
Dogs |
| Active Substances |
Milbemycin Oxime (A3 and A4), Praziquantel |
| Pharmaceutical Form |
Tablet |
| Therapeutic Group |
Anthelmintic |
| Authorisation Route |
Mutually Recognised |
| Legal Category |
POM-V |
| Controlled Drug Status |
Not a controlled drug |
| Marketing Authorisation Holder |
Krka d.d., Novo Mesto |
| Distributors |
<span>Centaur Services Limited</span><br /><br /><span>Henry Schein Animal Health</span><br /><br /><span>Movianto UK Limited</span><br /><br /><span>National Veterinary Services Limited</span><br /><br /><span>Potter Logistics Limited</span><br /><br /><span>UniDrug Distribution Group Ltd</span> |
| Territory |
Northern Ireland |
| SPC |
Milprazon 12.5 mg/125 mg Tablets for Dogs Weighing at Least 5 kg SPC |
| UKPAR |
Milprazon 12.5 mg/125 mg Tablets for Dogs Weighing at Least 5 kg UKPAR |
